Fennec Pharmaceuticals (FENC) P/E (2014 - 2026)
Fennec Pharmaceuticals (FENC) P/E from Sep 9, 2014 to Jul 21, 2026. The TTM Fennec Pharmaceuticals (FENC) P/E is -38.37. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Fennec Pharmaceuticals (FENC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -38.37 | +58.77% |
| 2025 | -24.17 | -96.08% |
| 2024 | -616.39 | +4101.12% |
| 2023 | -14.67 | +24.59% |
| 2022 | -11.78 | +78.44% |
| 2021 | -6.60 | -28.69% |
| 2020 | -9.25 | -8.41% |
| 2019 | -10.10 | -18.21% |
| 2018 | -12.35 | -51.49% |
| 2017 | -25.46 | +80.11% |
| 2016 | -14.14 | +49.74% |
| 2015 | -9.44 | -102.20% |
| 2014 | 428.56 | N/A |
Comparison Fennec Pharmaceuticals (FENC) P/E with competitors
Fennec Pharmaceuticals (FENC) P/E is -38.37.